Citations 1
Benefit-Risk Assessment Based on Number Needed to Treat and Number Needed to Harm: Atogepant vs Calcitonin Gene–Related Peptide Monoclonal Antibodies (P5-12.007)
Lalla, Anjana, Holle-Lee, Dagney, Kelton, Kari , Piron, Cristiano, Gandhi, Pranav , Sacco, Simona , Lalla, Anjana, Singh, Rashmi B. Halker , Pozo‐Rosich, Patricia , Nagy, Krisztian, Ailani, Jessica
Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available
